N Concordance 1 tumors and defining the indications for neoadjuvant therapies, likely to broaden 2 he efficacy of this immune modulator as neoadjuvant therapy we utilized the orth 3 ination of docetaxel and carboplatin as neoadjuvant therapy in patients with sta 4 ollowed by chemotherapy. Candidates for neoadjuvant therapy must also be eligibl 5 uvants to surgical resection, including neoadjuvant therapy to downstage tumors 6 sonography for evaluating the effect of neoadjuvant therapy for advanced esophag 7 identified as stage III3. The value of neoadjuvant therapy is most uncertain in 8 ed in those with T3. Patients receiving neoadjuvant therapy had a slight advanta 9 concurrent thoracic radiation is termed neoadjuvant therapy or induction therapy 10 rapeutic benefit for surgery following neoadjuvant therapy, it's not clear that 11 uesting immediate adjuvant treatment or neoadjuvant therapy, 156 subjects were e